Tim Grinstead is the founder of Visus Therapeutics. Visus Therapeutics has raised $56M in total funding. Latest round: Series A. Based in Seattle, WA.
Tim Grinstead serves as the Chief Operating Officer at Visus Therapeutics, a clinical-stage pharmaceutical company focused on innovative ophthalmic therapies. He was appointed to the executive leadership team in operations in June 2021. The company is developing the world's first presbyopia-correcting eye drop.
Full founder directory · Investor directory · Company funding database · Fundraising library